Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease. [electronic resource]
Producer: 20141106Description: 1349-62 p. digitalISSN:- 1365-2036
- Adalimumab
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bayes Theorem
- Certolizumab Pegol
- Crohn Disease -- drug therapy
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Infliximab
- Polyethylene Glycols -- therapeutic use
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.